Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain

ClinicalTrials.gov ID: NCT04688671

Public ClinicalTrials.gov record NCT04688671. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy and Safety of ETX 018810 in Subjects With Diabetic Peripheral Neuropathic Pain

Study identification

NCT ID
NCT04688671
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eliem Therapeutics (UK) Ltd.
Industry
Enrollment
167 participants

Conditions and interventions

Interventions

  • ETX-018810 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 8, 2020
Primary completion
Feb 8, 2022
Completion
Feb 17, 2022
Last update posted
Nov 6, 2023

2020 – 2022

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
Delta Clinical Research Mobile Alabama 36609
Arizona Research Center Phoenix Arizona 85053
Neuro-Pain Medical Cneter Fresno California 93710
Encompass Clinical Research Spring Valley California 91978
Diabetes Research Center Tustin California 92780
Chase Medical Research LLC Hamden Connecticut 06517
Charter Research Lady Lake Florida 32159
Cordova Research Institute Miami Florida 33155
Coral Research Clinic Corp Miami Florida 33186
Better Health Clinical Reseach Newnan Georgia 30265
Medisphere Medical Research Center Evansville Indiana 47714
StudyMetrix Research LLC City of Saint Peters Missouri 65810
Alliance for Multispeciality Research LLC Las Vegas Nevada 89119
Hassman Research Institute Berlin New Jersey 08009
IMA Clinical Research New York New York 10036
Upstate Clinical Research Associates Williamsville New York 14221
Midwest Clinical Research Center Dayton Ohio 45417
FutureSearch Trials of Neurology Austin Texas 78731
Alpine Research Organization Clinton Utah 84015
Jean Brown Research Salt Lake City Utah 84107
Wasatch Clinical Research LLC Salt Lake City Utah 84107
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04688671, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 6, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04688671 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →